Literature DB >> 8364568

Autosomal dominant supravalvular aortic stenosis: localization to chromosome 7.

T M Olson1, V V Michels, N M Lindor, G M Pastores, J L Weber, D J Schaid, D J Driscoll, R H Feldt, S N Thibodeau.   

Abstract

Supravalvular aortic stenosis (SVAS) is a localized or diffuse congenital narrowing of the ascending aorta which may occur sporadically, as a familial defect, or in association with Williams syndrome. Familial cases suggest an autosomal dominant gene defect but the underlying molecular basis of SVAS is unknown. In this study, we sought to localize the genetic defect in familial SVAS by linkage analysis in a large three generation family. A total of 44 polymorphic markers were examined for linkage, including 17 Southern blot-based RFLPs, 2 PCR-based RFLPs, and 25 microsatellites, primarily of the (CA)n repeat type. We report linkage of the disease phenotype to a highly informative (CA)n repeat marker, Mfd 50, at locus D7S440 which has been localized to chromosome arm 7q. Using a 100% penetrance model, which was more conservative than lower values of penetrance, a peak LOD score of 4.66 at a recombination frequency of 0.043 was found. A number of candidate genes have been localized to this region, including collagen 1A2, laminin B1, and elastin. Based on our preliminary linkage data, the abnormal microscopic appearance of aortic elastic fibers in SVAS, and analogous animal and human diseases associated with elastic fiber and vascular abnormalities, there is indirect evidence suggesting elastin as a possible candidate gene for this disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364568     DOI: 10.1093/hmg/2.7.869

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

Review 1.  Genetics of the extracellular matrix in aortic aneurysmal diseases.

Authors:  Chien-Jung Lin; Chieh-Yu Lin; Nathan O Stitziel
Journal:  Matrix Biol       Date:  2018-04-12       Impact factor: 11.583

2.  Williams-Beuren syndrome: historical aspects.

Authors:  Walter E Berdon; Patricia M Clarkson; Rita L Teele
Journal:  Pediatr Radiol       Date:  2010-12-01

3.  Decreased aortic diameter and compliance precedes blood pressure increases in postnatal development of elastin-insufficient mice.

Authors:  Victoria P Le; Russell H Knutsen; Robert P Mecham; Jessica E Wagenseil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

Review 4.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

5.  Growth of the aorta in children with Williams syndrome: does surgery make a difference?

Authors:  R F English; S D Colan; P M Kanani; J A Ettedgui
Journal:  Pediatr Cardiol       Date:  2003-04-30       Impact factor: 1.655

6.  Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome.

Authors:  E Nickerson; F Greenberg; M T Keating; C McCaskill; L G Shaffer
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

7.  Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene.

Authors:  A K Ewart; W Jin; D Atkinson; C A Morris; M T Keating
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

8.  Prevalence of scoliosis in Williams-Beuren syndrome patients treated at a regional reference center.

Authors:  Marcelo Loquette Damasceno; Alexandre Fogaça Cristante; Raphael Martus Marcon; Tarcísio Eloy Pessoa de Barros Filho
Journal:  Clinics (Sao Paulo)       Date:  2014-07       Impact factor: 2.365

Review 9.  Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development.

Authors:  Lauren E Parker; Andrew P Landstrom
Journal:  J Am Heart Assoc       Date:  2021-01-12       Impact factor: 6.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.